- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07819617
Submental Island Flap vs Radial Forearm Free Flap in Tongue Reconstruction (SIPF-RFFF)
Evaluation of Quality of Life Post Tongue Cancer Resection and Reconstruction Using Submental Island Pedicled Flap Versus Radial Forearm Free Flap
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Surgical reconstruction following tongue cancer resection is essential for restoring oral function, speech, swallowing, and facial aesthetics. The Radial Forearm Free Flap (RFFF) is widely considered a gold standard for soft tissue oral reconstruction; however, it requires microvascular expertise and carries donor-site morbidity. The Submental Island Pedicled Flap (SIPF) serves as an alternative, offering a reliable regional pedicled flap with local color match and simplified surgical execution without requiring microvascular anastomoses.
This retrospective observational cohort study aims to compare patients who received SIPF versus RFFF for tongue reconstruction. The primary objective is to evaluate health-related quality of life outcomes using the validated University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), alongside evaluating postoperative surgical outcomes and donor site morbidity.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Assuit
-
Asyut, Assuit, Egypt
- Faculty of Dental Medicine, Al-Azhar University (Assiut Branch)
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Adult patients (aged 18 years or older) diagnosed with squamous cell carcinoma of the tongue requiring partial or total glossectomy.
- Indication for immediate soft tissue reconstruction using either Submental Island Pedicled Flap (SIPF) or Radial Forearm Free Flap (RFFF).
- Patients eligible and cleared for major surgical resection and flap reconstruction under general anesthesia.
- Patient's informed consent to participate in the study and complete follow-up evaluations.
Exclusion Criteria:
- History of previous radiation therapy or surgical intervention in the head and neck region.
- Clinical or radiological evidence of nodal metastasis in level I submental lymph nodes (for SIPF candidates).
- Severe systemic comorbidities precluding major surgery or prolonged general anesthesia (ASA class IV or higher).
- Distance or inability to commit to the 12-month postoperative follow-up schedule and quality of life assessments.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
SIPF Group
Patients who underwent tongue reconstruction using Submental Island Pedicled Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a pedicled submental island flap.
|
|
RFFF group
Patients who underwent tongue reconstruction using Radial Forearm Free Flap following tongue cancer resection.
|
Surgical reconstruction of tongue defect following oncological resection using a microvascular radial forearm free flap.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
12-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
Tidsramme: 12 months post operatively
|
Unweighted composite score calculated as the mean of all 12 domains of the University of Washington Quality of Life Questionnaire version 4 (UW-QOL v4), evaluated at 12 months postoperatively and adjusted for baseline composite score using analysis of covariance (ANCOVA).
Scores range from 0 to 100, where higher scores indicate better quality of life.
|
12 months post operatively
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
6-Month Baseline-Adjusted Composite Quality of Life (UW-QOL v4)
Tidsramme: 6 months post operatively
|
Unweighted composite score of the 12 UW-QOL v4 domains evaluated at 6 months postoperatively and adjusted for baseline composite score using ANCOVA.
Scores range from 0 to 100.
|
6 months post operatively
|
|
Operative time
Tidsramme: Day of surgery (intraoperative)
|
Total duration of surgery measured in hours from initial skin incision to final closure.
|
Day of surgery (intraoperative)
|
|
Length of hospital stay
Tidsramme: From date of surgery to hospital discharge. Up to 30 days
|
Total duration of inpatient hospital admission measured in days from surgery until discharge.
|
From date of surgery to hospital discharge. Up to 30 days
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Mohamed Serag Attia, MSc, Al-Azhar University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AUAREC20240007-3
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .